Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib–Irinotecan Combo: A Case Study

Gastric cancer is common, especially in East Asian countries, and is associated with high recurrence and mortality rates. Currently, there is no standard third-line treatment for metastatic gastric cancer. In this report, we present the case of a 69-year-old man with advanced gastric cancer, whose t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Kailin, Chen, Xian, Li, Yong, Li, Wenzhu, Ye, Yongsong, He, Tingting, Wang, Wenjing, Zhang, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823137/
https://www.ncbi.nlm.nih.gov/pubmed/33500629
http://dx.doi.org/10.2147/OTT.S286024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823137/
https://www.ncbi.nlm.nih.gov/pubmed/33500629
http://dx.doi.org/10.2147/OTT.S286024

Ejemplares similares